Literature DB >> 9092509

Transient changes of the conformation of hemagglutinin of influenza virus at low pH detected by time-resolved circular dichroism spectroscopy.

T Korte1, K Ludwig, M Krumbiegel, D Zirwer, G Damaschun, A Herrmann.   

Abstract

Membrane fusion of influenza virus is mediated by a conformational change of the viral membrane protein hemagglutinin (HA) triggered by low pH. By near UV CD spectroscopy, which is sensitive to the arrangement and mobility of aromatic amino acids in proteins, we have monitored continuously with a time resolution of 5 s the kinetics of structural alterations of the ectodomain of HA isolated from different influenza virus strains (H1 (A/PR 8/34), H2 (A/Japan), and H3 (X31)). To establish a functional correlation to structural alterations of the HA ectodomain reflected by the CD, we have measured the kinetics of the virus-erythrocyte fusion and of the inactivation of fusion by low pH preincubation of viruses. At acidic pH we found a multiphasic behavior of the CD signal recorded at 283 nm. Upon lowering the pH we detected first an increase of the CD amplitude, which is associated with the formation of a fusion-competent state of HA. The initial increase was followed by a continuous decline of CD amplitude, which can be ascribed to a transformation into a fusion-inactivated conformation that is in its early phase reversible as found for A/Japan. The half-time of the different phases of the CD signal depended on the virus strain, the temperature, and the acidic pH. The results support recent hypotheses that the fusion-competent conformation is an intermediate of the fusion-inactivated structure of HA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9092509     DOI: 10.1074/jbc.272.15.9764

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Minimal aggregate size and minimal fusion unit for the first fusion pore of influenza hemagglutinin-mediated membrane fusion.

Authors:  J Bentz
Journal:  Biophys J       Date:  2000-01       Impact factor: 4.033

2.  Conformational intermediates and fusion activity of influenza virus hemagglutinin.

Authors:  T Korte; K Ludwig; F P Booy; R Blumenthal; A Herrmann
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

3.  Protonation and stability of the globular domain of influenza virus hemagglutinin.

Authors:  Qiang Huang; Robert Opitz; Ernst-Walter Knapp; Andreas Herrmann
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

4.  Thermal denaturation of influenza virus and its relationship to membrane fusion.

Authors:  Richard M Epand; Raquel F Epand
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

5.  Reversible stages of the low-pH-triggered conformational change in influenza virus hemagglutinin.

Authors:  Eugenia Leikina; Corinne Ramos; Ingrid Markovic; Joshua Zimmerberg; Leonid V Chernomordik
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

6.  Membrane fusion mediated by coiled coils: a hypothesis.

Authors:  J Bentz
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

7.  Measuring pKa of activation and pKi of inactivation for influenza hemagglutinin from kinetics of membrane fusion of virions and of HA expressing cells.

Authors:  Aditya Mittal; Tong Shangguan; Joe Bentz
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

8.  A mechanism of protein-mediated fusion: coupling between refolding of the influenza hemagglutinin and lipid rearrangements.

Authors:  M M Kozlov; L V Chernomordik
Journal:  Biophys J       Date:  1998-09       Impact factor: 4.033

9.  pH-induced conformational changes of membrane-bound influenza hemagglutinin and its effect on target lipid bilayers.

Authors:  C Gray; L K Tamm
Journal:  Protein Sci       Date:  1998-11       Impact factor: 6.725

10.  Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin.

Authors:  S J Plotch; B O'Hara; J Morin; O Palant; J LaRocque; J D Bloom; S A Lang; M J DiGrandi; M Bradley; R Nilakantan; Y Gluzman
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.